Outcomes of patients with metastatic renal cell carcinoma that do not meet eligibility criteria for clinical trials von Heng, D.Y.C., Choueiri, T.K., Rini, B.I., Lee, J., Yuasa, T., Pal, S.K., Srinivas, S., Bjarnason, G.A., Knox, J.J., MacKenzie, M., Vaishampayan, U.N., Tan, M.H., Rha, S.Y., Donskov, F., Agarwal, N., Kollmannsberger, C., North, S., Wood, L.A.

Volltext

Primary anti-vascular endothelial growth factor (VEGF)-refractory metastatic renal cell carcinoma: clinical characteristics, risk factors, and subsequent therapy von Heng, D.Y., MacKenzie, M.J., Vaishampayan, U.N., Bjarnason, G.A., Knox, J.J., Tan, M.H., Wood, L., Wang, Y., Kollmannsberger, C., North, S., Donskov, F., Rini, B.I., Choueiri, T.K.

Volltext

First-, second-, third-line therapy for mRCC: benchmarks for trial design from the IMDC von Ko, J J, Choueiri, T K, Rini, B I, Lee, J-L, Kroeger, N, Srinivas, S, Harshman, L C, Knox, J J, Bjarnason, G A, MacKenzie, M J, Wood, L, Vaishampayan, U N, Agarwal, N, Pal, S K, Tan, M-H, Rha, S Y, Yuasa, T, Donskov, F, Bamias, A, Heng, D Y C

Volltext

Racial disparity in incidence patterns and outcome of kidney cancer von Vaishampayan, U.N., Do, H., Hussain, M., Schwartz, K.

Volltext

A randomised phase II trial of three dosing regimens of radium-223 in patients with bone metastatic castration-resistant prostate cancer von Sternberg, C.N., Saad, F., Graff, J.N., Peer, A., Vaishampayan, U.N., Leung, E., Rosenbaum, E., Gurney, H., Epstein, R.J., Davis, I.D., Wu, B., Trandafir, L., Wagner, V.J., Hussain, M.

Volltext

Activity of enzalutamide in men with metastatic castration-resistant prostate cancer is affected by prior treatment with abiraterone and/or docetaxel von Cheng, H H, Gulati, R, Azad, A, Nadal, R, Twardowski, P, Vaishampayan, U N, Agarwal, N, Heath, E I, Pal, S K, Rehman, H-t, Leiter, A, Batten, J A, Montgomery, R B, Galsky, M D, Antonarakis, E S, Chi, K N, Yu, E Y

Volltext

First-line (1L) or second-line (2L) avelumab monotherapy in patients (pts) with advanced renal cell carcinoma (aRCC) enrolled in the phase Ib JAVELIN solid tumor trial von Vaishampayan, U.N., Schöffski, P., Ravaud, A., Borel, C., Song, T., Guenther, S., Grewal, J., Gulley, J.

Volltext

Randomized trial of androgen deprivation therapy (ADT) + enzalutamide (Arm A) versus ADT + bicalutamide (Arm B) in metastatic hormone sensitive prostate cancer (mHSPC) von Vaishampayan, U.N., Heilbrun, L., Monk, P., Sonpavde, G., Tejwani, S., Heath, E.I., Fontana, J., Chinni, S.

Volltext

Clinical outcomes of patients with metastatic renal cell carcinoma (mRCC) treated with vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors (TKI) and mamm... von Graham, J., Wells, J.C., McKay, R., Vaishampayan, U.N., Hansen, A., Donskov, F., Bjarnason, G.A., Beuselinck, B., De Velasco, G., Duh, M.S., Huynh, L., Chang, R., Zanotti, G., Ramaswamy, K., Choueiri, T.K., Heng, D.Y.C.

Volltext

A single-institution experience with concurrent capecitabine and radiation therapy in gastrointestinal malignancies von Vaishampayan, U.N, Ben-Josef, E, Philip, P.A, Vaitkevicius, V.K, Du, W, Levin, K.J, Shields, A.F

Volltext

A randomized phase IIa study of quantified bone scan response in patients with metastatic castration-resistant prostate cancer (mCRPC) treated with radium-223 dichloride alone or i... von Petrylak, D.P., Vaishampayan, U.N., Patel, K.R., Higano, C.S., Albany, C., Dawson, N.A., Mehlhaff, B.A., Quinn, D.I., Nordquist, L.T., Wagner, V.J., Siegel, J., Trandafir, L., Sartor, O.

Volltext

Development of cabozantinib for the treatment of prostate cancer [Corrigendum] von Vaishampayan, Ulka

Volltext

803PRandomized trial of androgen deprivation therapy (ADT) + enzalutamide (Arm A) versus ADT + bicalutamide (Arm B) in metastatic hormone sensitive prostate cancer (mHSPC) von Vaishampayan, U N, Heilbrun, L, Monk, P, Sonpavde, G, Tejwani, S, Heath, E I, Fontana, J, Chinni, S

Volltext

877PFirst-line (1L) or second-line (2L) avelumab monotherapy in patients (pts) with advanced renal cell carcinoma (aRCC) enrolled in the phase Ib JAVELIN solid tumor trial von Vaishampayan, U N, Schöffski, P, Ravaud, A, Borel, C, Song, T, Guenther, S, Grewal, J, Gulley, J

Volltext

Tumor downstaging as an intermediate endpoint to assess the activity of neoadjuvant systemic therapy in patients with muscle‐invasive bladder cancer von Martini, Alberto, Jia, Rachel, Ferket, Bart S., Waingankar, Nikhil, Plimack, Elizabeth R., Crabb, Simon J., Harshman, Lauren C., Yu, Evan Y., Powles, Thomas, Rosenberg, Jonathan E., Pal, Sumanta K., Vaishampayan, Ulka N., Necchi, Andrea, Wiklund, N. Peter, Mehrazin, Reza, Mazumdar, Madhu, Sfakianos, John P., Galsky, Matthew D.

Volltext

870PA phase IIa study of radium-223 dichloride (Ra-223) alone or in combination with abiraterone acetate or enzalutamide in metastatic castration-resistant prostate cancer (mCRPC) von Petrylak, D P, Vaishampayan, U N, Patel, K R, Higano, C S, Albany, C, Dawson, N A, Mehlhaff, B A, Quinn, D I, Nordquist, L T, Wagner, V J, Shen, J, Trandafir, L, Sartor, O

Volltext

LBA54ENTRATA: Randomized, double-blind, phase II study of telaglenastat (tela; CB-839) + everolimus (E) vs placebo (pbo) + E in patients (pts) with advanced/metastatic renal cell c... von Motzer, R J, Lee, C-H, Emamekhoo, H, Matrana, M, Percent, I, Hsieh, J J, Hussain, A, Vaishampayan, U N, Graham, R, Liu, S, McCune, S, Shaheen, M, Parmar, H, Shen, Y, Whiting, S H, Tannir, N M

Volltext

Nomogram-based Prediction of Overall Survival in Patients with Metastatic Urothelial Carcinoma Receiving First-line Platinum-based Chemotherapy: Retrospective International Study o... von Necchi, Andrea, Sonpavde, Guru, Lo Vullo, Salvatore, Giardiello, Daniele, Bamias, Aristotelis, Crabb, Simon J, Harshman, Lauren C, Bellmunt, Joaquim, De Giorgi, Ugo, Sternberg, Cora N, Cerbone, Linda, Ladoire, Sylvain, Wong, Yu-Ning, Yu, Evan Y, Chowdhury, Simon, Niegisch, Gunter, Srinivas, Sandy, Vaishampayan, Ulka N, Pal, Sumanta K, Agarwal, Neeraj, Alva, Ajjai, Baniel, Jack, Golshayan, Ali-Reza, Morales-Barrera, Rafael, Bowles, Daniel W, Milowsky, Matthew I, Theodore, Christine, Berthold, Dominik R, Daugaard, Gedske, Sridhar, Srikala S, Powles, Thomas, Rosenberg, Jonathan E, Galsky, Matthew D, Mariani, Luigi

Volltext

Blastic mantle cell lymphoma associated with Burkitt‐type translocation and hypodiploidy von Vaishampayan, Ulka N., Mohamed, Anwar N., Dugan, Michael C., Bloom, Robert E., Palutke, Margarita

Volltext

889PClinical outcomes of patients with metastatic renal cell carcinoma (mRCC) treated with vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitors (TKI) and... von Graham, J, Wells, J C, McKay, R, Vaishampayan, U N, Hansen, A, Donskov, F, Bjarnason, G A, Beuselinck, B, De Velasco, G, Duh, M S, Huynh, L, Chang, R, Zanotti, G, Ramaswamy, K, Choueiri, T K, Heng, D Y C

Volltext